Dr. Lin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3655 Lomita Blvd
Ste 101
Torrance, CA 90505Phone+1 310-543-1677Fax+1 310-543-9838
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1997 - 2000
Albert Einstein College of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 2000 - 2025
FL State Medical License 1999 - 2002
MN State Medical License 1998 - 2000- National Board of Physicians and Surgeons Internal Medicine
Publications & Presentations
PubMed
- 384 citationsDaratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trialPeter M. Voorhees, Jonathan L. Kaufman, Jacob P. Laubach, Douglas W. Sborov, Brandi Reeves
Blood. 2020-08-20 - 136 citationsThe novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivoDavid M. Lucas, Ryan B. Edwards, Gerard Lozanski, Derek A. West, Jungook D. Shin
Blood. 2009-05-07 - 73 citationsFlavopiridol, Fludarabine, and Rituximab in Mantle Cell Lymphoma and Indolent B-Cell Lymphoproliferative DisordersThomas S. Lin, Kristie A. Blum, Diane Beth Fischer, Sarah M. Mitchell, Amy S. Ruppert
Journal of Clinical Oncology. 2010-01-20
Grant Support
- Monoclonal Antibody Therapy In B-Cell CLL.National Cancer Institute2005–2008
- A Phase I Study Of Single Agent Flavopiridol In B-Cell *National Cancer Institute2006–2007
- A Phase I Study Of The AKT Inhibitor 17-AAG In CLLNational Cancer Institute2005–2006
- A Novel Dosing Schedule Of Flavopiridol In CLLNational Cancer Institute2005–2006
- A Phase I Study Of Flavopiridol, Fludarabine And RituximabNational Center For Research Resources2005
- A Dose Escalation Study Of Flavopiridol (Nsc 649890)National Center For Research Resources2004–2005
- Phase I Study Of Flavopiridol, Fludarabine And RituximabNational Center For Research Resources2004
- Monoclonal Antibody Therapy In B-Cell CLLNational Cancer Institute2004
Other Languages
- Chinese (Mandarin), Japanese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
